Molecular Biology Department

The Molecular Biology laboratory was created for the continuous upgrade of the provided health services to the Cypriot citizens.

BIOIATRIKI Healthcare Group is committed to the provision of high-quality services, invests in modern infrastructure, highly trained personnel and high technology to meet the diagnostic needs created by the COVID-19 pandemic in Cypriot society.

The department follows the international analysis protocols and is equipped with an automatic genetic material elution analyzer in combination with 2 state-of-the-art Real Time PCR devices which can provide reliable results for the control of various viruses (influenza, Sars-Cov-2, RSV) as well as sexually transmitted diseases, according to the guidelines of the World Health Organization (WHO).